Compare ASNS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASNS | EVGN |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Agricultural Chemicals |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 10.9M |
| IPO Year | 2022 | N/A |
| Metric | ASNS | EVGN |
|---|---|---|
| Price | $3.04 | $1.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $50.00 | $3.50 |
| AVG Volume (30 Days) | ★ 137.7K | 51.3K |
| Earning Date | 11-14-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,367,000.00 | ★ $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $198.35 | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $2.64 | $0.95 |
| 52 Week High | $17.80 | $2.42 |
| Indicator | ASNS | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 72.87 | 41.97 |
| Support Level | $2.86 | $1.03 |
| Resistance Level | $3.30 | $1.14 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 82.04 | 31.12 |
Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.